title: A high affinity ligand for GABAA-receptor containing alpha5 subunit antagonizes ethanol's neurobehavioral effects in Long-Evans rats.
abstract: BACKGROUND
  Previously, we reported that the GABA(A)receptor containing alpha(5)subunit played a significant role in the reinforcing actions of EtOH in rats selectively bred to consume alcohol. However, the role of the alpha(5) receptor in regulating the neurobehavioral effects of EtOH in outbred rats is not known.
  
  
  OBJECTIVE
  In the present study, RY024, a novel benzodiazepine (BDZ) inverse agonist with high affinity (K(d) approximately 0.40 nM) and selectivity (approximately 67.3-fold) for the alpha(5)receptor, was investigated for its capacity to antagonize EtOH's reinforcing, motor impairing, and sedative effects in Long-Evans rats.
  
  
  METHODS
  Rats were trained to lever press for EtOH under a fixed-ratio 1 schedule of reinforcement. Subsequent studies evaluated EtOH's motor-impairing effects in an oscillating bar task, while EtOH's sedative effects were measured in the open field.
  
  
  RESULTS
  RY024 (0.125-3.5 mg/kg; IP) markedly reduced EtOH-maintained responding with no effects on water responding, except for the highest dose. RY024 (3.0-15 mg/kg; IP) also reversed the motor impairing effects of a moderate (0.75 g/kg), and intoxicating EtOH dose (1.25 g/kg) in the absence of intrinsic effects. Finally, RY024 (7.5 mg/kg) attenuated the sedation produced by the 1.25 g/kg EtOH dose; however, it failed to attenuate the sedation induced by the 0.75 g/kg EtOH dose. Given alone, RY024 exhibited intrinsic effects in the open field.
  
  
  CONCLUSIONS
  The results suggest the GABA(A)receptor containing alpha(5)subtype plays an important role in regulating the reinforcing, motor-impairing, and sedative effects of alcohol in outbred rats.
authors.affiliation: Psychobiology Program, Department of Psychology, Indiana University-Purdue University, Indianapolis, IN 46202, USA.
authors.forename: Peter F
authors.initials: PF
authors.lastname: McKay
authors.forename: Katrina L
authors.initials: KL
authors.lastname: Foster
authors.forename: Dynesha
authors.initials: D
authors.lastname: Mason
authors.forename: Rancia
authors.initials: R
authors.lastname: Cummings
authors.forename: Marin
authors.initials: M
authors.lastname: Garcia
authors.forename: La Shone
authors.initials: LS
authors.lastname: Williams
authors.forename: Collette
authors.initials: C
authors.lastname: Grey
authors.forename: Shannan
authors.initials: S
authors.lastname: McCane
authors.forename: Xiaohui
authors.initials: X
authors.lastname: He
authors.forename: James M
authors.initials: JM
authors.lastname: Cook
authors.forename: Harry L
authors.initials: HL
authors.lastname: June
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects / Q000502:physiology; D001569:Benzodiazepines / Q000494:pharmacology*; D004347:Drug Interactions; D000431:Ethanol / Q000037:antagonists & inhibitors* / Q000097:blood / Q000494:pharmacology*; D058787:GABA-A Receptor Antagonists; D008024:Ligands; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D021122:Protein Subunits / Q000037:antagonists & inhibitors; D051381:Rats; D020318:Rats, Long-Evans; D012054:Reinforcement, Psychology
chemical_list: D058787:GABA-A Receptor Antagonists; D008024:Ligands; D021122:Protein Subunits; C464899:RY 024; D001569:Benzodiazepines; D000431:Ethanol